278 related articles for article (PubMed ID: 15004877)
41. Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU report 38.
Datta NR; Kumar S; Das KJ; Pandey CM; Halder S; Ayyagari S
Radiother Oncol; 2001 Jul; 60(1):15-24. PubMed ID: 11410299
[TBL] [Abstract][Full Text] [Related]
42. Comparison of high-dose-rate intracavitary brachytherapy dosimetry with and without anesthesia in patients with cervical carcinoma.
Sharma DN; Chaudhari P; Sharma S; Gupta L; Jagadesan P; Rath GK; Julka PK
J Appl Clin Med Phys; 2014 Mar; 15(2):4670. PubMed ID: 24710456
[TBL] [Abstract][Full Text] [Related]
43. [Optimization of dose distribution in combined irradiation of uterine cervix cancer with gamma-ray cesium-137 and X-9 MeV].
Lewocki M
Ann Acad Med Stetin; 1996; 42():199-222. PubMed ID: 9199121
[TBL] [Abstract][Full Text] [Related]
44. Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer?
Kim HJ; Kim S; Ha SW; Wu HG
Tumori; 2008; 94(3):327-32. PubMed ID: 18705399
[TBL] [Abstract][Full Text] [Related]
45. Comparison between DVH-based doses and ICRU point-based doses to the rectum and the bladder using CT-based high-dose rate brachytherapy to the cervix.
Rangarajan R; Subramanian S; Gopalakrishnan K
Med Dosim; 2018 Autumn; 43(3):276-283. PubMed ID: 29198390
[TBL] [Abstract][Full Text] [Related]
46. A dosimetric comparison of two high-dose-rate brachytherapy planning systems in cervix cancer: standardized template planning vs. computerized treatment planning.
Patone H; Souhami L; Parker W; Evans M; Duclos M; Portelance L
Brachytherapy; 2008; 7(3):254-9. PubMed ID: 18579447
[TBL] [Abstract][Full Text] [Related]
47. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects.
Fellner C; Pötter R; Knocke TH; Wambersie A
Radiother Oncol; 2001 Jan; 58(1):53-62. PubMed ID: 11165682
[TBL] [Abstract][Full Text] [Related]
48. Problems in reporting doses and volumes during multiple high-dose-rate intracavitary brachytherapy for carcinoma cervix as per ICRU Report 38: a comparative study using flexible and rigid applicators.
Datta NR; Basu R; Das KJ; Rajasekar D; Pandey CM; Ayyagari S
Gynecol Oncol; 2003 Nov; 91(2):285-92. PubMed ID: 14599857
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of rectal dose during high-dose-rate intracavitary brachytherapy for cervical carcinoma.
Sha RL; Reddy PY; Rao R; Muralidhar KR; Kudchadker RJ
Med Dosim; 2011; 36(4):377-82. PubMed ID: 21144733
[TBL] [Abstract][Full Text] [Related]
50. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
51. Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer.
Suzuki O; Yoshioka Y; Isohashi F; Morimoto M; Kotsuma T; Kawaguchi Y; Konishi K; Nakamura S; Shiomi H; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1329-34. PubMed ID: 18439763
[TBL] [Abstract][Full Text] [Related]
52. Optimisation techniques in vaginal cuff brachytherapy.
Tuncel N; Garipagaoglu M; Kizildag AU; Andic F; Toy A
Br J Radiol; 2009 Nov; 82(983):936-40. PubMed ID: 19470571
[TBL] [Abstract][Full Text] [Related]
53. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
[TBL] [Abstract][Full Text] [Related]
54. Dosimetric comparison of tandem and Ovoids vs. tandem and ring for intracavitary gynecologic applications.
Levin D; Menhel J; Rabin T; Pfeffer MR; Symon Z
Med Dosim; 2008; 33(4):315-20. PubMed ID: 18973861
[TBL] [Abstract][Full Text] [Related]
55. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
[TBL] [Abstract][Full Text] [Related]
56. Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
Bajwa HK; Talluri AK; Maqbool A; Reddy D; Singareddy R; Sresty NM; Raju AK
Brachytherapy; 2022; 21(2):151-157. PubMed ID: 34756698
[TBL] [Abstract][Full Text] [Related]
57. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
58. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
59. High-dose-rate-intracavitary brachytherapy applications and the difference in the bladder and rectum doses: a study from rural centre of Maharashatra, India.
Jain VS; Sarje MB; Singh KK; Umberkar R; Shrivastava R; Jain SM
J Cancer Res Ther; 2007; 3(2):116-20. PubMed ID: 17998737
[TBL] [Abstract][Full Text] [Related]
60. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
